Study details
Enrolling now
Dime La VerDAD: Verify, Debunk, and Disseminate
University of Chicago
NCT IDNCT06417762ClinicalTrials.gov data as of Apr 2026
Target enrollment
1,400
Study length
about 3.8 years
Ages
18–99
Locations
4 sites in IA, IL, MI
About this study
This trial is testing a program that helps community health workers share personal stories on social media to combat vaccine misinformation. The goal is to see if this approach can change people's opinions about COVID-19 and flu vaccines in Hispanic communities.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Science Communication Curriculum Cohort 1
- 2.Participate in Science communication curriculum Cohort 2
- 3.Participate in Science communication curriculum Cohort 3
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low4%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Infectious, Respiratory